Baxter International Inc. (BAX) Valuation
Historical valuation analysis based on 500 data points (2024-08-30 to 2026-08-28)
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative se...
Baxter International Inc. (BAX) currently trades at a P/E ratio of 159.38 (historical range: 7.72–179.65, median: 154.79), placing it at the 63th percentile — above its historical average, P/S ratio of 1.18 (range: 0.74–1.85, 42th percentile — near its historical average), EV/EBITDA of 172.58 (range: 17.17–2099.05, 66th percentile).
Baxter International Inc. appears slightly overvalued relative to its historical range, with most valuation metrics above their median levels.
Historical Valuation Metrics
| Metric | Current | Min | Median | Max | Percentile | Assessment |
|---|---|---|---|---|---|---|
| P/E Ratio | 159.38 | 7.72 | 154.79 | 179.65 | 63th | above its historical average |
| P/S Ratio | 1.18 | 0.74 | 1.29 | 1.85 | 42th | near its historical average |
| EV/EBITDA | 172.58 | 17.17 | 106.57 | 2099.05 | 66th | above its historical average |
| FCF Yield | 0.04 | 0.03 | 0.03 | 0.04 | 99th | cheap relative to its history |